Technical Analysis for 0A3S - Novavax Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 7.68 | 0.00% | 0.00 |
Earnings due: May 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Flat | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Sell Signal | Bearish | 0.00% | |
| Boomer Sell Setup | Bearish Swing Setup | 0.00% | |
| 200 DMA Support | Bullish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% |
Free Daily (Stock) Chart Reading
Novavax Inc. Description
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Classification
Keywords: Biotechnology Vaccine Influenza Malaria
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.315 |
| 52 Week Low | 4.03 |
| Average Volume | 6,178 |
| 200-Day Moving Average | 7.59 |
| 50-Day Moving Average | 7.68 |
| 20-Day Moving Average | 7.68 |
| 10-Day Moving Average | 7.68 |
| Average True Range | 2.85 |
| RSI (14) | 0.00 |
| ADX | 45.46 |
| +DI | 0.06 |
| -DI | 0.16 |
| Chandelier Exit (Long, 3 ATRs) | -0.86 |
| Chandelier Exit (Short, 3 ATRs) | 13.35 |
| Upper Bollinger Bands | 7.68 |
| Lower Bollinger Band | 7.68 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0011 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.97 | ||||
| Resistance 3 (R3) | 11.50 | 9.59 | 11.26 | ||
| Resistance 2 (R2) | 9.59 | 8.49 | 9.82 | 11.02 | |
| Resistance 1 (R1) | 8.63 | 7.81 | 9.11 | 9.11 | 10.78 |
| Pivot Point | 6.72 | 6.72 | 6.96 | 6.96 | 6.72 |
| Support 1 (S1) | 5.77 | 5.63 | 6.24 | 6.24 | 4.57 |
| Support 2 (S2) | 3.86 | 4.95 | 4.09 | 4.33 | |
| Support 3 (S3) | 2.90 | 3.86 | 4.09 | ||
| Support 4 (S4) | 3.38 |
